Noxopharm Ltd

Research Noxopharm Ltd (NOX) on Bullrun: market cap AUD 28.57M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerNOX
• ExchangeAU
• CountryAustralia
• SectorHealthcare
• IndustryBiotechnology
• CurrencyAUD
• Market capAUD 28.57M
• Financial periodFY2024
• Net income-AUD 3.58M
• Free cash flow-AUD 684.31K

Valuation Snapshot

latest market cap is AUD 28.57M.

About Noxopharm Ltd

Noxopharm Limited, a biotech company, engages in the discovering and developing treatments for cancer and inflammation, and mRNA vaccines in Australia. It develops Sofra, a platform that focuses on the development of immunomodulators for mRNA vaccines and mRNA therapeutics, as well as for the treatment of autoimmune diseases;

Frequently asked questions

What is Noxopharm Ltd's market cap?

Noxopharm Ltd's market capitalization is AUD 28.57M.

What does Noxopharm Ltd do?

Noxopharm Limited, a biotech company, engages in the discovering and developing treatments for cancer and inflammation, and mRNA vaccines in Australia.